INNOVATIVE HEALTH PRACTICES
ID: BAA-GH-OAA-2024Type: Special Notice
Overview

Buyer

AGENCY FOR INTERNATIONAL DEVELOPMENTAGENCY FOR INTERNATIONAL DEVELOPMENT

NAICS

All Other Professional, Scientific, and Technical Services (541990)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/ef467544c4ee4331b6fac3a72ccc0276/view
Timeline
    Description

    Special Notice: AGENCY FOR INTERNATIONAL DEVELOPMENT is seeking innovative health practices through a Broad Agency Announcement (BAA). The purpose is to co-create, co-design, co-invest, and collaborate on research and development interventions to reduce disease and mortality rates worldwide. Organizations and companies are invited to submit an Expression of Interest (EOI) to generate novel tools and approaches for improved health outcomes in low-and-middle-income countries (LIMIC).

    Point(s) of Contact
    SHARON D DAVIS
    (202) 916-2644
    SHDAVIS@USAID.GOV
    Files
    Title
    Posted
    BAA-GH-OAA-2024 Innovative Health Practices.pdf
    Lifecycle
    Title
    Type
    INNOVATIVE HEALTH PRACTICES
    Currently viewing
    Special Notice
    Similar Opportunities
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Office of Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative medical countermeasures (MCMs) to address public health emergencies. The initiative invites submissions across various Areas of Interest (AOIs), including but not limited to vaccine development, diagnostics, and therapeutics for infectious diseases and chemical threats. This program is crucial for enhancing the nation's preparedness against health security threats, particularly in light of recent global health challenges. Interested parties must register on SAM.gov and adhere to specific submission deadlines, with multiple awards anticipated based on scientific merit and funding availability. For further inquiries, respondents can contact Aarati Singal or Lara Emmons at DRIVeAcquisitions@hhs.gov.
    2026 NIAID DMID Omnibus Broad Agency Announcement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the 2026 NIAID DMID Omnibus Broad Agency Announcement (BAA) aimed at advancing medical countermeasures against infectious diseases. This opportunity encompasses two primary research areas: the development of therapeutics, vaccines, and diagnostics for antimicrobial-resistant pathogens, and the creation of direct acting antivirals targeting viruses with pandemic potential. The initiative is critical for enhancing public health responses to emerging infectious threats and includes funding estimates of up to $8.5 million for Research Area 001 and $20 million for Research Area 002, with proposals due to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) platform, starting around November 22, 2024. For further inquiries, interested parties may contact Swee L. Teo at teosl@niaid.nih.gov or Brian Madgey at brian.madgey@nih.gov.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Active
    Health And Human Services, Department Of
    Solicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) is seeking proposals for various health research and development services. This opportunity is typically used for experimental development and healthcare services. The place of performance is in the USA. For more information, please contact BARDA-BAA@hhs.gov. The deadline for proposal submission is September 25, 2028, at 4:30 PM Eastern Time.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
    Energy Sector Self-Reliance BAA
    Active
    Agency For International Development
    The AGENCY FOR INTERNATIONAL DEVELOPMENT has issued a Combined Synopsis/Solicitation notice for the procurement of support services in the SUPPORT- PROFESSIONAL: ENGINEERING/TECHNICAL industry. The notice titled "Energy Sector Self-Reliance BAA" seeks opportunities to co-create, co-design, and co-invest in the research, development, piloting, and scaling of innovative and cost-effective interventions to support the advancement of self-reliant energy sectors in developing countries. The service/item being procured is aimed at addressing the diverse set of challenges faced by countries striving to achieve universal access to reliable, affordable, and sustainable energy services. The procurement is open to organizations, companies, government agencies, academic and research institutions, and investors. The goal is to engage with a wide range of implementing partners and service providers within the global energy sector to strengthen national and regional energy systems. Subsequent Addenda will provide further details on how to participate in this opportunity.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), has announced the FY24 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to support innovative research projects that enhance regulatory science, with a focus on health, medical, and biotechnology advancements. The awarded contracts, totaling over $24 million, cover a range of critical topics including drug safety, gene therapy, and methodologies for assessing pediatric opioid exposure, reflecting the federal government's commitment to fostering research initiatives that improve healthcare delivery and regulatory processes. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), is soliciting proposals through a Broad Agency Announcement (BAA) for innovative solutions in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. The BAA invites participation from a wide range of eligible sources, including educational institutions, nonprofit organizations, and private industry, to develop technologies such as sensor systems, aerosol technologies, and decontamination methods. This initiative is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' effectiveness on the battlefield and in homeland defense. Interested parties can submit preproposals at any time, with contact points for inquiries being Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil and Lionel Love at lionel.d.love.civ@army.mil.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for the FY25 Broad Agency Announcement (BAA) aimed at advancing research and development in regulatory science. This opportunity invites submissions from various entities, including private organizations and academic institutions, to conduct research that supports FDA's mission to protect public health, with a focus on modernizing product development, enhancing post-market surveillance, and improving public health preparedness. Proposals must align with FDA priorities and demonstrate innovative approaches to address critical knowledge gaps, with submissions due by February 24, 2025. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    NEEDIPEDIA BROAD AGENCY ANNOUNCEMENT - BAA
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking NATIONAL DEFENSE R&D SERVICES for a BROAD AGENCY ANNOUNCEMENT - BAA. This announcement aims to gather innovative ideas from interested and qualified sources to enhance operating efficiency and effectiveness in operations. The agency is open to participation from both traditional and non-traditional members, such as large businesses, small businesses, independent consultants, academic institutions, and consortium participants. The goal is to acquire preeminent technological and/or innovation capability to support the agency's national and international mission requirements. This solicitation is a follow-on to HHM402-19-S-0001. For more information, contact Stephen E. Lee at stephen.lee@dodiis.mil or ideas2action@dodiis.mil.